agilon health (NYSE:AGL – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.07), Briefing.com reports. The company had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative net margin of 5.67% and a negative return on equity of 26.15%. The firm’s quarterly revenue was up 38.7% on a year-over-year basis. During the same period in the previous year, the company earned ($0.04) EPS. agilon health updated its Q3 2024 guidance to EPS and its FY 2024 guidance to EPS.
agilon health Stock Performance
agilon health stock traded down $0.58 during mid-day trading on Wednesday, reaching $5.65. 5,834,350 shares of the company traded hands, compared to its average volume of 5,150,248. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.33 and a quick ratio of 1.33. agilon health has a fifty-two week low of $4.41 and a fifty-two week high of $20.37. The company has a market capitalization of $2.32 billion, a price-to-earnings ratio of -8.06 and a beta of 0.60. The firm’s fifty day moving average is $6.54 and its two-hundred day moving average is $6.00.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the stock. Robert W. Baird assumed coverage on shares of agilon health in a report on Thursday, May 30th. They issued a “neutral” rating and a $6.00 price target for the company. Baird R W upgraded shares of agilon health to a “hold” rating in a report on Thursday, May 30th. Royal Bank of Canada restated an “outperform” rating and issued a $8.00 price target on shares of agilon health in a report on Wednesday. Evercore ISI boosted their price target on shares of agilon health from $5.50 to $7.00 and gave the company an “in-line” rating in a report on Tuesday, July 9th. Finally, Truist Financial boosted their price target on shares of agilon health from $6.40 to $6.50 and gave the company a “hold” rating in a report on Friday, May 24th. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $9.10.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
See Also
- Five stocks we like better than agilon health
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- What Are Bonds? A High-Level Overview
- Want to Profit on the Downtrend? Downtrends, Explained.
- Super Micro Stock Drops Sharply After Earnings on Margin Concerns
- What is the Dogs of the Dow Strategy? Overview and Examples
- Lyft’s First-Ever Profit, but the Outlook Is a Speed Bump
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.